Summary by Moomoo AI
Vertex Pharmaceuticals Incorporated announced that its 2024 Annual Meeting of Shareholders will be held virtually on May 15, 2024. Shareholders will vote on the election of directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2024, an advisory vote on 2023 executive compensation, and two shareholder proposals regarding special shareholder meeting improvement and a report on racial and gender pay gaps. The meeting will facilitate shareholder participation from any location at no cost. Shareholders of record as of March 18, 2024, are entitled to vote. The board recommends voting for the election of all director nominees, for the ratification of Ernst & Young LLP, for the 2023 named executive officer compensation, and against the shareholder proposals. The company's proxy materials are available online, and shareholders can vote by internet, telephone, or mail prior to the meeting.